| Tag | Content |
|---|
EnhancerAtlas ID | HS139-57532 |
Organism | Homo sapiens |
Tissue/cell | Myotube |
Coordinate | chr9:134953000-134955020 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| RREB1 | MA0073.1 | chr9:134954546-134954566 | TGGTTGCGGGTGGGTGGTGG | - | 7.28 | | SOX10 | MA0442.2 | chr9:134953456-134953467 | AAAACAAAGAA | + | 6.62 | | ZNF263 | MA0528.1 | chr9:134953994-134954015 | GCCACCTCCTCCTCCTCCTCC | - | 8.14 | | ZNF263 | MA0528.1 | chr9:134954000-134954021 | TCCTCCTCCTCCTCCTCCATC | - | 8.97 | | ZNF263 | MA0528.1 | chr9:134953997-134954018 | ACCTCCTCCTCCTCCTCCTCC | - | 9.76 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_33425 | chr9:134952921-134955899 | H2171 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | AACCTAAGCC CATTTACACT CCAGGGTAAA GCCAGCCCCC AGGATCAAAG ACTGCTCTTC 60
AAACCATCCA TCAGAAGTCC CTTAAGAAGA AATACTTTTT GAAAGGTTAA AAAATACTTG 120
GGACACTTAA AAAAAAAAAC CCTAAATGAG AGTTTATCTG ACTTTAAAAC AGAGCTTCTG 180
GTGCCATTCC AAAGGAGGAA AAAAAAGGTA AGGGCAGTAG AATCAATAAG ACCCCCATAA 240
TCAGAAATTA ACAACTCAAA TTCATCCCTG CAGTGGGGAG GAGACTTTCT GGAATTTTGA 300
AATGTGGTAT AACACTGCCT CTCACTAAGA GTTTTCAGAC CCACGTGCAG ATCATTACAC 360
TTGGCAGAAC AGCAAGTACC TGATTAAATG ATGATTATTT ATCATTCACA TAGGGATAGA 420
TTTGTACATG ATGCTTCACA GATGGTAAAA CTTAACAAAA CAAAGAAGAG ATAAAATAAA 480
CAAATGGAAT GGGAAGACAC CACTGAGGTG GCTGTGTCAA ACAAACACAC TTCAGTCTAG 540
CAGGAAAACC CTAGAGAAGC TTGGGAAAGC GAGCCAACAA GAGCACATTC CAGGAGTACG 600
TTCTGAGGGG CCAGTCCCAA ACTGCCAACA AAAGACTCTC TAGGAACAGC TTCTTATGCC 660
ACATTCATTT TGGAATCATC AGCCACCTTC TTCTTGGCAC TACTGTACAA AGATTTAAGA 720
AGGCAAAAGG ATAATGTCAG CACTCTTAAA GTTTCTATTT AAAATGGTGA AGGGTTATAA 780
TATCCTGAAC ATTACAAAGG GAAGTAACTC GGAGAGAAAA TGGAAAGAAA ACAGAAGATA 840
GGGAAGAATA GCCAGTGCAT CCCCTGAAGC AGAGAAAGTA TTAACTGGTG CTCGGCGCGG 900
TGCCAGAGAA CAGCAAGCGG ATGTGGGCGT TGAGGAGGGC TGTGTGATTT ACGGCAACTA 960
CTTAGGGGGA AAACAAAAAG GCACCCATCA TTTGGCCACC TCCTCCTCCT CCTCCTCCAT 1020
CCTACCTCCT CTTTCCATCT GGTTACTAAG GAGACCAAGT TGAAAAAACA AAAATCCAAC 1080
CAGTCCAGAA ATCAAAGGAT GACTAGCTCA CCAAATGCTT TCCCCTACTC AGGTCAGTTC 1140
TGAGAAGTAA AAGGCAAAAA TCCTGAAATT CTAACCTTCC TGGGAAGGAC TGACTCTCTT 1200
ATAAAACAGA AGGCAAGTTC AGGACCTAAG CAATCAAGAA GTGCCTACTA TGTGCCAGGC 1260
CCTTTACAAA CATCCTCTCA TTTAATTCTT ACAACACTTA AAAAGTGTAA GTGAAGAAGG 1320
TACTTTGTAA GGAAGAGGAG GAAAAGTGGA ATCCTTAACC CTAAAAGACT ACAAATTAAG 1380
AAGCAGGGGC GTTAAGCATA AGTAATTAAA CTGGTTAAGA GATTAGAGAG TAGGTCTCTA 1440
CTGCGGAAGG AACTCCCACA GGAGTGGGAG TGAGGAAACT GATCAGGTGG TTTGGGAGCG 1500
GTTAGGGGAA AAGGTGAAGA CAGCTCAAGG CCTGGCCGGT CCGTCGTGGT TGCGGGTGGG 1560
TGGTGGTGGA ACTGATGAAG TCCAAGTTCA GGGCCGGGGA ATTGGGGCTA ATCAGATCGG 1620
GTGCACTTGG GTTTGGAGCC GACTGACCAG GTCCTGTCTG TACTATTACT ACATTCGGAT 1680
CAGACGTGAT GGGGCACAGA GGGCCTACAG GTGAGAAACC TGCCAAGCTC AGAGAAGTGG 1740
AAGTTCATGG GAAAAGCATG CCTCCTTGTT AGGAATGGAA CCGCCACAGA AGAGGTCGAG 1800
GATGGCGGAA GACAAACAGG ACCAGGAGGC CAGGAGAAGC AAGACGAGAA AGCGGGGATG 1860
GTGTTAAGAT GTCCCTGAGG GACAGGCAGA GGCTTGGAGA ACAAGAAGAG AAAGAACAGG 1920
GATCAAGGGA AACGGAGAAC AGCCCCTGCC TGGGAAGACT CGAGCGACGT AGGGGCAGGG 1980
TCGGAGCGGG GCCGGTCCCC GACCCCGGCC CCTTCAGCCG 2020
|
